JP2022507505A5 - - Google Patents
Info
- Publication number
- JP2022507505A5 JP2022507505A5 JP2021526491A JP2021526491A JP2022507505A5 JP 2022507505 A5 JP2022507505 A5 JP 2022507505A5 JP 2021526491 A JP2021526491 A JP 2021526491A JP 2021526491 A JP2021526491 A JP 2021526491A JP 2022507505 A5 JP2022507505 A5 JP 2022507505A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- membered
- aryl
- substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862768805P | 2018-11-16 | 2018-11-16 | |
| US62/768,805 | 2018-11-16 | ||
| US201862769165P | 2018-11-19 | 2018-11-19 | |
| US201862769151P | 2018-11-19 | 2018-11-19 | |
| US62/769,165 | 2018-11-19 | ||
| US62/769,151 | 2018-11-19 | ||
| US201962795981P | 2019-01-23 | 2019-01-23 | |
| US62/795,981 | 2019-01-23 | ||
| US201962796361P | 2019-01-24 | 2019-01-24 | |
| US201962796356P | 2019-01-24 | 2019-01-24 | |
| US62/796,356 | 2019-01-24 | ||
| US62/796,361 | 2019-01-24 | ||
| US201962898241P | 2019-09-10 | 2019-09-10 | |
| US62/898,241 | 2019-09-10 | ||
| PCT/US2019/061531 WO2020102574A1 (en) | 2018-11-16 | 2019-11-14 | The compounds and compositions for treating conditions associated with nlrp activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022507505A JP2022507505A (ja) | 2022-01-18 |
| JP2022507505A5 true JP2022507505A5 (https=) | 2022-11-01 |
Family
ID=70731718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526491A Pending JP2022507505A (ja) | 2018-11-16 | 2019-11-14 | Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230059136A1 (https=) |
| EP (1) | EP3880658A1 (https=) |
| JP (1) | JP2022507505A (https=) |
| CN (1) | CN113227055A (https=) |
| WO (1) | WO2020102574A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000027251A1 (it) * | 2020-11-13 | 2022-05-13 | Donatella Boschi | Inibitori della diidroorotato deidrogenasi umana (hdhodh) per l'uso come antivirali |
| JP7825294B2 (ja) * | 2021-02-10 | 2026-03-06 | ハンジョウ イノゲート ファーマ カンパニー リミテッド | Ｎｌｒｐ３阻害剤としての化合物 |
| US11932630B2 (en) | 2021-04-16 | 2024-03-19 | Novartis Ag | Heteroaryl aminopropanol derivatives |
| WO2025078263A1 (en) | 2023-10-11 | 2025-04-17 | Syngenta Crop Protection Ag | Microbiocidal pyridyl pyrazole derivatives |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW221049B (https=) * | 1991-12-20 | 1994-02-11 | Lilly Co Eli | |
| KR102727059B1 (ko) * | 2015-02-16 | 2024-11-05 | 더 유니버서티 어브 퀸슬랜드 | 설포닐우레아와 관련 화합물 및 그 용도 |
| US11597706B2 (en) * | 2016-04-18 | 2023-03-07 | Novartis Ag | Compounds and compositions for treating conditions associated with NLRP activity |
| ES2940611T3 (es) * | 2016-04-18 | 2023-05-09 | Novartis Ag | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP |
| KR20180134395A (ko) * | 2016-04-19 | 2018-12-18 | 인네이트 튜머 이뮤니티, 인코포레이티드 | Nlrp3 조정제 |
| CN111094242B (zh) * | 2017-07-24 | 2024-02-09 | 诺华股份有限公司 | 用于治疗与nlrp活性相关的病症的化合物和组合物 |
-
2019
- 2019-11-14 US US17/293,787 patent/US20230059136A1/en not_active Abandoned
- 2019-11-14 CN CN201980085826.3A patent/CN113227055A/zh active Pending
- 2019-11-14 JP JP2021526491A patent/JP2022507505A/ja active Pending
- 2019-11-14 WO PCT/US2019/061531 patent/WO2020102574A1/en not_active Ceased
- 2019-11-14 EP EP19817075.5A patent/EP3880658A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507505A5 (https=) | ||
| JP2022507065A5 (https=) | ||
| JP2022505525A5 (https=) | ||
| JP2022507506A5 (https=) | ||
| JP2020528889A5 (https=) | ||
| JP2019519598A5 (https=) | ||
| ES2927777T3 (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP | |
| CA2899706C (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
| ES2640063T3 (es) | Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis B | |
| HRP20251344T1 (hr) | SPOJEVI I PRIPRAVCI ZA LIJEČENJE STANJA POVEZANIH S AKTIVNOŠĆU NLRP-a | |
| JP2019518071A5 (https=) | ||
| JP2022506898A5 (https=) | ||
| JP2020537657A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2024512154A5 (https=) | ||
| JP2022513959A (ja) | 大環状化合物及び疾患の処置におけるそれらの使用 | |
| JP2019515952A5 (https=) | ||
| AU2020218367A1 (en) | Therapeutic agents and methods of treatment | |
| CN106414473B (zh) | 多烯大环内酯衍生物 | |
| CN105001165A (zh) | 取代的二氨基嘧啶其组合物，和用其治疗的方法 | |
| WO2024088408A1 (zh) | 一种含氮杂环化合物、其药学上可接受的盐及其制备方法与应用 | |
| TW201617331A (zh) | 異吲哚啉衍生物 | |
| CN105051046A (zh) | β-氨基羰基类化合物、其制备方法、药物组合物及其用途 | |
| JP2021524856A5 (https=) | ||
| CN117677622A (zh) | 磺酰亚胺酰胺化合物及其用途 |